VAS & COVID-19

Guidance on Vitamin A Supplementation in the Context of COVID-19

The Global Alliance for Vitamin A (GAVA) and its partner agencies have developed the following products to provide countries with evidence-informed programmatic guidance on how to plan and implement vitamin A supplementation (VAS) in the context of COVID-19. These resources will be updated as new evidence emerges and the COVID-19 pandemic progresses.

GAVA’s resources on VAS and COVID-19 are also available in French – click here to be redirected to GAVA’s French resources.

 

GAVA Webinar
GAVA hosted a webinar on July 9, 2020, to review the operational guide on the administration of VAS for preschool-aged children in the context of COVID-19, and to answer questions from program managers and those working in the field. Click on the image to the left to view the webinar recording and to access the PowerPoint slides used during the webinar.

GAVA Consensus Statement

The GAVA consensus statement provides recommendations on VAS for preschool-aged children through campaigns and routine health and nutrition services during the COVID-19 pandemic. The statement serves as a consensus document based on GAVA’s review of WHO guidance for other services that use mass campaigns (e.g. vaccination) and routine health delivery platforms.

Operational guidance on the administration of VAS for preschool-aged children in the context of COVID-19

This GAVA document provides comprehensive guidance on the programmatic adaptations recommended to safely administer VAS to preschool-aged children and maintain the continuity of VAS services during the COVID-19 pandemic. It contains guidance for program managers on preparing for the delivery of VAS, as well as detailed step-by-step instructions on how to safely deliver VAS using appropriate infection prevention and control measures.